Edi Brogi

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma
    Paola de Candia
    Program in Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 37:1032-41. 2006
  2. doi request reprint Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays
    E Brogi
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Oncol 22:2597-603. 2011
  3. ncbi request reprint Classification of benign endometrial glandular cells in cervical smears from postmenopausal women
    Edi Brogi
    Department of Pathology, Cytology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 96:60-6. 2002
  4. ncbi request reprint Paired ductal lavage and fine-needle aspiration specimens from patients with breast carcinoma
    Edi Brogi
    Cytology Laboratory Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Diagn Cytopathol 33:370-5. 2005
  5. ncbi request reprint The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients
    Edi Brogi
    Department of Pathology, Breast Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 12:173-80. 2005
  6. doi request reprint Lobular carcinoma, not only a classic
    Edi Brogi
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Breast J 16:S10-4. 2010
  7. ncbi request reprint Benign and malignant spindle cell lesions of the breast
    Edi Brogi
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Semin Diagn Pathol 21:57-64. 2004
  8. ncbi request reprint Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study
    Edi Brogi
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 98:2170-6. 2003
  9. pmc A CXCL1 paracrine network links cancer chemoresistance and metastasis
    Swarnali Acharyya
    Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cell 150:165-78. 2012
  10. doi request reprint The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 251:583-91. 2010

Detail Information

Publications54

  1. ncbi request reprint Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma
    Paola de Candia
    Program in Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 37:1032-41. 2006
    ..Further investigations are required to define the functions of Id4 in the human normal breast and in mammary neoplasia...
  2. doi request reprint Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays
    E Brogi
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Oncol 22:2597-603. 2011
    ..Development of brain metastasis in patients with breast carcinoma correlates with poor outcome. Identification of tumor characteristics associated with breast cancer brain metastases (BCBM) could help identify patients at risk...
  3. ncbi request reprint Classification of benign endometrial glandular cells in cervical smears from postmenopausal women
    Edi Brogi
    Department of Pathology, Cytology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 96:60-6. 2002
    ..However, PMP women on hormone replacement therapy (HRT) sometimes may experience endometrial shedding. The significance of such a finding has not been investigated in detail...
  4. ncbi request reprint Paired ductal lavage and fine-needle aspiration specimens from patients with breast carcinoma
    Edi Brogi
    Cytology Laboratory Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Diagn Cytopathol 33:370-5. 2005
    ..To increase the sensitivity of DL, the number of epithelial cells required for a satisfactory sample should be higher than previously set...
  5. ncbi request reprint The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients
    Edi Brogi
    Department of Pathology, Breast Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 12:173-80. 2005
    ..The goal of intraoperative sentinel lymph node (SLN) examination is to avoid reoperation for a positive SLN, but the ideal method of intraoperative SLN examination remains unclear, and published results vary widely...
  6. doi request reprint Lobular carcinoma, not only a classic
    Edi Brogi
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Breast J 16:S10-4. 2010
    ..A pleomorphic variant of invasive lobular carcinoma has also been described. Here, we summarize our evolving knowledge of in situ and invasive lobular neoplasia and highlight the implications for patient management...
  7. ncbi request reprint Benign and malignant spindle cell lesions of the breast
    Edi Brogi
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Semin Diagn Pathol 21:57-64. 2004
    ..The differential diagnosis and diagnostic work-up of these lesions is discussed, and their clinical treatment and prognosis briefly summarized...
  8. ncbi request reprint Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study
    Edi Brogi
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 98:2170-6. 2003
    ..Ductal lavage (DL) is a new method for the sampling of breast epithelium. Data regarding its sensitivity in the detection of epithelial abnormalities, including carcinoma in situ (CIS), remains limited...
  9. pmc A CXCL1 paracrine network links cancer chemoresistance and metastasis
    Swarnali Acharyya
    Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cell 150:165-78. 2012
    ..This network of endothelial-carcinoma-myeloid signaling interactions provides a mechanism linking chemoresistance and metastasis, with opportunities for intervention...
  10. doi request reprint The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 251:583-91. 2010
    ..There remains variation in the use of radiation therapy (RT) in women with ductal carcinoma in situ (DCIS), despite prospective randomized trials documenting its benefit in reducing the risk of ipsilateral breast tumor recurrence (IBTR)...
  11. doi request reprint DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors
    Yong H Wen
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 36:1700-8. 2012
    ....
  12. doi request reprint Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up
    Christine A Wynveen
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Am J Surg Pathol 35:1-14. 2011
    ..This type of tumor is strongly estrogen receptor positive and hormonal therapy should be pursued for its management, whereas the benefit of radiation after lumpectomy remains unclear...
  13. doi request reprint Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up
    Lee K Tan
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 26:1803-9. 2008
    ..However, there is no consensus regarding the optimal method for pathologic examination of SLN, or the prognostic significance of SLN micrometastases...
  14. doi request reprint Non-mammary metastases to the breast and axilla: a study of 85 cases
    Deborah F Delair
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 26:343-9. 2013
    ..This finding emphasizes the need to accurately identify these tumors as metastases in order to avoid unnecessary procedures and treatments in these patients...
  15. doi request reprint Should breast density influence patient selection for breast-conserving surgery?
    Nimmi S Kapoor
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY, USA
    Ann Surg Oncol 20:600-6. 2013
    ..In a previous study of the relationship between breast density and primary tumor features, we observed a higher mastectomy rate in patients with extremely dense breasts. Here we examine possible reasons for this finding...
  16. ncbi request reprint Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma
    Adriana D Corben
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 34:1211-6. 2010
    ..Morphologic identification of ciliated cells and "peg" cells is most helpful to recognize this benign inclusion, and positive immunoreactivity for WT1 and/or PAX8 can be used to support the diagnosis...
  17. doi request reprint Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ
    Udo Rudloff
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 28:3762-9. 2010
    ..However, they have never been proven to improve survival, and in themselves carry rare but serious risks. Individualized estimation of IBTR risk would assist in decision making regarding the various treatment options for women with DCIS...
  18. ncbi request reprint Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma
    Yong Hannah Wen
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 26:1197-203. 2013
    ..Our results show that EGFR mutation-specific antibodies could be an additional tool distinguishing primary versus metastatic carcinomas in the lung. False-positivity can be seen in breast carcinoma but is extremely rare (1%)...
  19. doi request reprint Ductal carcinoma in situ: morphology-based knowledge and molecular advances
    Dara S Ross
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Adv Anat Pathol 20:205-16. 2013
    ..Morphology-based knowledge, immunohistochemistry, and molecular advances in DCIS are the subjects of this review...
  20. doi request reprint Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy
    Alice Y Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 118:4944-52. 2012
    ..The authors evaluated the clinical characteristics, natural history, and outcomes of patients who had ≤1 cm, lymph node-negative, triple-negative breast cancer (TNBC)...
  21. doi request reprint Radioactive seed localization with 125I for nonpalpable lesions prior to breast lumpectomy and/or excisional biopsy: methodology, safety, and experience of initial year
    Lawrence T Dauer
    Department of Medical Physics, Memorial Sloan Kettering CancerCenter, New York, NY 10021, USA
    Health Phys 105:356-65. 2013
    ..RSL has been shown to be a safe and effective procedure for preoperative localization under mammographic and ultrasound guidance, which can be managed with the use of customized radiation protection controls...
  22. ncbi request reprint Serpins promote cancer cell survival and vascular co-option in brain metastasis
    Manuel Valiente
    Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cell 156:1002-16. 2014
    ..By protecting cancer cells from death signals and fostering vascular co-option, anti-PA serpins provide a unifying mechanism for the initiation of brain metastasis in lung and breast cancers. ..
  23. doi request reprint Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma
    Xiang H F Zhang
    Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cell 154:1060-73. 2013
    ....
  24. ncbi request reprint Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision
    Melissa P Murray
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 119:1073-9. 2013
    ..Here, the authors report findings from 72 consecutive lesions with LN at CNB and prospective surgical excision (EXB)...
  25. doi request reprint Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole
    Mary Morrogh
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Surg Res 176:121-32. 2012
    ....
  26. doi request reprint Focal extravasated mucin in breast core needle biopsies: is surgical excision always necessary?
    Marcia Edelweiss
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA
    Breast J 19:302-9. 2013
    ..Our data suggest that surgical excision of lesions yielding EM without epithelial atypia at CNB may not be necessary provided that imaging and pathologic findings are concordant...
  27. doi request reprint Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer
    Mary L Gemignani
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    J Nucl Med 54:1697-702. 2013
    ..The purpose of this study was to correlate (18)F-FES PET and ER expression in patients with primary, operable breast cancer...
  28. doi request reprint Cadherin-catenin complex dissociation in lobular neoplasia of the breast
    Mary Morrogh
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY 10065, USA
    Breast Cancer Res Treat 132:641-52. 2012
    ..Decreasing membranous catenin expression in tandem with increasing levels of TWIST across the spectrum of lobular lesions suggests that CCC dissociation is a progressive process...
  29. ncbi request reprint Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy
    Udo Rudloff
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 115:1203-14. 2009
    ....
  30. ncbi request reprint Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
    Thordur Oskarsson
    Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Nat Med 17:867-74. 2011
    ..These findings link TNC to pathways that support the fitness of metastasis-initiating breast cancer cells and highlight the relevance of TNC as an extracellular matrix component of the metastatic niche...
  31. pmc ID genes mediate tumor reinitiation during breast cancer lung metastasis
    Gaorav P Gupta
    Cancer Biology and Genetics Program, Molecular Cytology Core Facility, Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Proc Natl Acad Sci U S A 104:19506-11. 2007
    ..These results shed light on the proliferative mechanisms that initiate metastatic colonization, and they implicate Id1 and Id3 as mediators of this malignant function in the TN subgroup of breast cancers...
  32. doi request reprint Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation
    Yong Hannah Wen
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Breast Cancer Res Treat 135:93-102. 2012
    ..Our results document substantial expression of Id4 in most TNBCs, which could result in functional downregulation of BRCA1 pathways in these tumors...
  33. pmc The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites
    Hua Gao
    Cell Biology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cell 150:764-79. 2012
    ..These findings reveal that metastasis-initiating cells need to overcome organ-specific antimetastatic signals in order to undergo reactivation...
  34. doi request reprint Challenges in the interpretation of breast core biopsies
    Adriana D Corben
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Breast J 16:S5-9. 2010
    ..The most prudent approach for the pathologist is to provide sufficient information to prompt a surgical excision without overdiagnosing the lesion, thus placing the patient into the appropriate therapeutic algorithm...
  35. doi request reprint Cancelled stereotactic biopsy of calcifications not seen using the stereotactic technique: do we still need to biopsy?
    Sandra B Brennan
    Departments of Radiology, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, 300 East 66th Street, 731, New York, NY, 10065, USA
    Eur Radiol 24:907-12. 2014
    ..To determine the frequency of cancelled stereotactic biopsy due to non-visualisation of calcifications, and assess associated features and outcome data...
  36. ncbi request reprint Impact of margin assessment method on positive margin rate and total volume excised
    Tracy Ann Moo
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 21:86-92. 2014
    ..We examined our institutional experience with three different margin assessment methods used by six experienced breast surgeons...
  37. pmc TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition
    Marko Stankic
    Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, 415 East 68 th Street, New York, NY 10065, USA Department of Molecular Biology, Weill Cornell Medical College, 445 East 69 th Street, New York, NY 10021, USA
    Cell Rep 5:1228-42. 2013
    ..Collectively, these studies underscore the importance of Id-mediated phenotypic switching during distinct stages of breast cancer metastasis. ..
  38. ncbi request reprint Papilloma diagnosed at MRI-guided vacuum-assisted breast biopsy: is surgical excision still warranted?
    Sandra B Brennan
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 199:W512-9. 2012
    ..The objective of our study was to determine the frequency of cancer at surgery in breast lesions yielding papilloma at MRI-guided 9-gauge vacuum-assisted biopsy (VAB) and to determine whether any features are associated with cancer upgrade...
  39. ncbi request reprint Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis
    Tari A King
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 14:2510-8. 2007
    ..However, several lines of evidence suggest that phenotypic effects may result from BRCA haploinsufficiency...
  40. pmc Subtle variations in Pten dose determine cancer susceptibility
    Andrea Alimonti
    Cancer Genetics Program, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Nat Genet 42:454-8. 2010
    ..We present an alterative working model for cancer development in which subtle reductions in the dose of TSGs predispose to tumorigenesis in a tissue-specific manner...
  41. pmc Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer
    Patrick G Morris
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer Prev Res (Phila) 4:1021-9. 2011
    ..The presence of CLS-B may be a biomarker of increased breast cancer risk or poor prognosis...
  42. doi request reprint Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy
    Janice S Sung
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States
    Eur J Radiol 82:1453-7. 2013
    ..To evaluate the safety and efficacy of pre-operative I-125 radioactive seed localization (RSL) as an alternative to wire localization (WL)...
  43. ncbi request reprint Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging
    Jennifer H Menell
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Breast J 11:382-90. 2005
    ..In this study, MRI was significantly more sensitive than mammography in DCIS detection. In women with known or suspected DCIS, MRI may have an important role to play in assessing the extent of disease in the breast...
  44. pmc A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Maura N Dickler
    Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 14:7878-83. 2008
    ..To evaluate the efficacy and toxicity of erlotinib plus bevacizumab in patients with metastatic breast cancer (MBC), targeting the epidermal growth factor receptor (EGFR/HER1) and the vascular endothelial growth factor (VEGF) pathway...
  45. ncbi request reprint Fine-needle aspiration cytology of mammary adenomyoepithelioma: a study of 12 patients
    Pratibha Iyengar
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 108:250-6. 2006
    ..Incomplete excision of this lesion is associated with a greater risk of recurrence. Although the histology of AME is well characterized, its cytomorphology has not been assessed in a large series...
  46. ncbi request reprint Desmoid tumors (fibromatoses) of the breast: a 25-year experience
    Heather B Neuman
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
    Ann Surg Oncol 15:274-80. 2008
    ..Breast desmoid tumors are rare and often clinically mistaken for carcinoma. We reviewed our 25-year institutional experience with breast desmoid tumors...
  47. pmc Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
    Tanaya Shree
    Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Genes Dev 25:2465-79. 2011
    ..This study highlights the importance of integrated targeting of the tumor and its microenvironment and implicates macrophages and cathepsins in blunting chemotherapeutic response...
  48. doi request reprint The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?
    Mustafa Khasraw
    Evelyn H Lauder Breast and Imaging Center, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
    Curr Oncol Rep 13:17-25. 2011
    ....
  49. ncbi request reprint Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations
    Noah D Kauff
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 97:1601-8. 2003
    ....
  50. doi request reprint Synchronous breast cancers with different morphologic and molecular phenotypes occurring in Lynch syndrome: what does the heterogeneity imply?
    Clare D'Arcy
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 35:1743-8. 2011
    ....
  51. ncbi request reprint Carcinoid tumorlets simulate pulmonary metastases in women with breast cancer
    Farbod Darvishian
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 37:839-44. 2006
    ..Consideration should be given to the possibility of PCTs in patients with breast cancer with pulmonary nodules, even if multiple...
  52. ncbi request reprint Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody
    Jonathan Perk
    Cancer Biology and Genetics Program and Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer Res 66:10870-7. 2006
    ..These results suggest that further refinement of Id1 expression patterns in a variety of tumor types will be necessary to identify and study the functional roles played by Id1 in human neoplastic processes...
  53. ncbi request reprint Primary lymphoma of the breast: a case of marginal zone B-cell lymphoma
    Gladys L Giron
    Breast Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am Surg 70:720-5. 2004
    ..Delivery of radiation therapy and chemotherapy is tailored according to the histologic grade, stage of disease, and overall patient condition. This report summarizes the current knowledge reflected in the literature...
  54. ncbi request reprint Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?
    Sharon Wing Wai Chan
    Department of Surgery, United Christian Hospital, Kowloon, Hong Kong, China
    Ann Surg 247:143-9. 2008
    ....